Telehealth is rapidly becoming an integral part of the Australian healthcare system, offering patients convenient access to medical services from the comfort of their own homes. However, as with any new technology, there can be questions and confusion surrounding coverage and payment. In this blog, we’ll explore the ins and outs of telehealth and insurance...
Telehealth Doctor for Diabetes: When considering how to use telehealth to manage your diabetes, it is helpful to know what devices you’ll need for the video visits. While most patients can connect via smartphones or tablets, a desktop or laptop computer will enhance your ability to view shared data. Telehealth Doctor for Treating Diabetes You’ll...
Amazon’s voice assistant, Alexa, may soon be able to make telehealth doctor appointments through Teladoc. To use this service, customers will create an Alexa voice ID. Then, when the time comes to connect with a Teladoc call center, patients will give permission to the virtual assistant. Alexa For Telehealth Doctor Amazon is not allowed to...
ResApp Health Sign Software Licensing Agreement with Phenix Health On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by...
ASX listed digital health company ResApp has signed a memorandum of understanding with health products manufacturer RB, formerly known as Reckitt Benckiser, to develop a smartphone app for consumers that uses ResApp’s cough-based algorithms to identify different respiratory conditions. For the full article please visit:
The average GP consultation take about six minutes. That figure is very significant in the context of the two-year, non-exclusive commercial software licensing agreement Resapp Health [ASX:RAP] has just signed with Phenix Health Pty Ltd. Phenix Health Pty Ltd is an integrative medical tech company founded in 2015 as a spin-off from its Australia-wide after-hours...
In March, ResApp announced to have completed the initial integration of ResAppDx-EU into Coviu’s telehealth platform and that ResApp and Coviu had agreed upon a per test fee (range of $ 5-10 per test) for the use of ResAppDx-EU. Meanwhile, ResApp also executed Joint Development Agreement with Phenix Health for integration of ResAppDx-EU into Phenix’s Australian telehealth...
Wheezo asthma diagnostic and monitoring technology Respiri has developed its wheezo device and eHealth software as a service technology to support the management of respiratory health. Machine learning is employed to detect wheeze via the wheezo device and app. Wheeze is a typical asthma symptom and is common in other respiratory disorders. The technology is...
* RESPIRI LTD – ANNOUNCES SIGNING OF A JOINT DEVELOPMENT AGREEMENT (JDA) WITH PHENIX HEALTH PTY LTD * RESPIRI-UNDER DEAL,WHEEZO EHEALTH SAAS MONITORING PLATFORM INTEGRATED INTO PHENIX PROPRIETARY TELEHEALTH PLATFORM, PATIENT DASHBOARDS & ASTHMA PLANS https://au.investing.com/news/stock-market-news/briefrespiri-announces-signing-of-a-joint-development-agreement-with-phenix-health-2092571
ASX-listed ResApp Health will partner with Brisbase-headquartered telehealth provider Phenix Health to integrate ResApp’s acute respiratory diagnostic test into Phenix’s telehealth app. ResApp has recently completed a similar integration of ResAppDx-EU into Coviu’s telehealth platform and is expecting to have it available for use in a few months. The company is also about to launch a consumer-focused...
Phenix Health delivers online health services 24/7 provided by Australian doctors and healthcare professionals.